A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine
Clinical trial NCT03901482 · COMPLETED
Trial details
- NCT number
- NCT03901482
- Sponsor
- Satsuma Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2020-07-31
- Enrollment
- 1201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.